Finance
Roche targets double-digit market share in weight loss, aims to catch up with novo nordisk, handelsblatt reports
Published by Global Banking & Finance Review®
Posted on March 3, 2026
1 min readLast updated: March 3, 2026
Quick Summary
Roche CEO Thomas Schinecker told Handelsblatt the company aims for a double‑digit share in the weight‑loss market and to rank among the top three, seeking to close the gap on dominant rivals like Novo Nordisk.
Roche Targets Top Three in Double-Digit Weight Loss Market Share Ambitions
Roche's Strategic Goals in the Weight Loss Market
CEO Outlines Market Share Ambitions
BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche is aiming for a double-digit market share in the weight loss market and wants to close the gap on its Danish rival Novo Nordisk, its CEO told Germany's Handelsblatt business daily.
Top Three Market Position Targeted
"We expect to be among the top three in the market at the very least," Roche Chief Executive Thomas Schinecker said in an interview with the newspaper published on Tuesday.
Reporting and Editorial Credits
(Writing by Linda Pasquini; Editing by Christopher Cushing)
Key Takeaways
- •Roche is targeting a double‑digit share of the global weight‑loss market, hoping to position itself at least in the top three—challenging leaders Novo Nordisk and Eli Lilly.
- •The weight‑loss drug market is rapidly expanding—from about $72 billion to $139 billion by 2030—with GLP‑1 therapies dominating over 90 % market share held by Novo Nordisk and Lilly. Roche's push reflects growing competition and opportunity in the space (nypost.com).
- •Roche’s plan builds on its major biotech partnership with Zealand Pharma, investing over $5 billion to co‑develop injectable obesity treatments like petrelintide and CT‑388 combinations to rival products from Novo and Lilly (investopedia.com).
References
Frequently Asked Questions about Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
1What market share is Roche aiming for in the weight loss sector?
Roche is targeting a double-digit share in the weight loss market.
2Who is Roche's main competitor in the weight loss market?
Roche is aiming to close the gap with Danish rival Novo Nordisk.
3What is Roche's goal for its market position in weight loss treatments?
Roche expects to be among the top three companies in the weight loss market.
4Who announced Roche's ambitions in the weight loss market?
Roche CEO Thomas Schinecker announced these ambitions in an interview.